Clinical Trials Logo

Filter by:
NCT ID: NCT04969237 Completed - Post COVID Clinical Trials

Vitamine D in Post-COVID Patients

VD-PCS
Start date: August 1, 2021
Phase:
Study type: Observational

In this study routineously collected vitamine D values will compared to healthy cohorts from this year and previous years.

NCT ID: NCT04968912 Completed - Sjogren's Syndrome Clinical Trials

A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

Start date: September 21, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of nipocalimab in participants with primary Sjogren's syndrome (pSS) versus placebo.

NCT ID: NCT04967612 Completed - Healthy Clinical Trials

Visual Perception After Virtual Implantation

Start date: May 10, 2021
Phase: N/A
Study type: Interventional

Evaluation of visual perception through diffractive optical lens designs by virtual implantation.

NCT ID: NCT04967534 Completed - Frailty Syndrome Clinical Trials

Efficacy of WB-EMS in Frail Older People

Start date: July 21, 2021
Phase: N/A
Study type: Interventional

Exercise in general and resistance training (RT) in particular have demonstrated positive effects on frailty outcomes, including physical functioning. However, frail older people with functional impairments are among the least physically active and have problems reaching high-intensity levels. Whole-body electromyostimulation (WB-EMS) allows the simultaneous innervation of all large muscle groups by external electrical stimulation, inducing a high-intensity RT at a low subjective effort level. The efficacy of WB-EMS in frail older people has yet to be determined. The primary objective of this study is to investigate the efficacy of WB-EMS in frail older people.

NCT ID: NCT04963738 Completed - Renal Impairment Clinical Trials

A Study of JNJ-73763989 in Adult Participants With Renal Impairment

Start date: September 22, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics (PK) of a single subcutaneous (SC) dose of JNJ-73763989 in adult participants with renal impairment compared with healthy participants with normal renal function.

NCT ID: NCT04963517 Completed - Bone Sarcoma Clinical Trials

Exercise Intervention for Bone Tumor Patients

proGAIT
Start date: August 7, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

The proGait-study is a two-arm exercise intervention study for AYA-patients with lower extremity tumor endoprosthesis in the follow-up care. This clinical trial will investigate the effects of an 8-week personalized multi-modal exercise intervention of lower extremity muscles on gait quality in adolescents and young adults with cancer diagnosis beginning at least 12 months after endoprosthesis implantation.

NCT ID: NCT04963400 Completed - Non-cardiac Disease Clinical Trials

Impact of Hospitalization on High-sensitivity Cardiac Troponin T Concentrations Depending on Disease Severity

Start date: July 14, 2021
Phase:
Study type: Observational

We aim to examine, whether hospitalization is associated with higher high-sensitivity cardiac troponin T (hs-cTnT) serum concentrations in patients without a cardiac disease.

NCT ID: NCT04962594 Completed - Healthy Infants Clinical Trials

Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s)

Start date: September 2, 2021
Phase: N/A
Study type: Interventional

This is a randomized, controlled, multicenter, double-blind study of healthy term infants. The primary objective of the trial is to demonstrate the safety of a a starter infant formula supplemented with pre- and probiotic(s) by comparing the growth of infants randomized to the experimental formula versus the control formula from enrolment to 4 months of age.

NCT ID: NCT04961346 Completed - Incisional Hernia Clinical Trials

RCT Comparing Lightweight vs. Heavyweight Meshes in Incisional Hernia Repair

Start date: September 2004
Phase: N/A
Study type: Interventional

In this randomized, controlled, prospective multicentre clinical trial with a parallel group design a large-pore, lightweight polypropylene mesh (Ultrapro®) is compared to a small-pore, heavyweight polypropylene mesh (Premilene®), within a standardized, retromuscular mesh augmentation to identify the superiority of the lightweight mesh. Included patients are examined at five scheduled follow-up visits (5 and 21 days, 4, 12 and 24 months after surgery). The primary outcome criterion is foreign body sensation 12 month after surgery. Further secondary endpoint criteria are the occurrence of haematoma or haematoma requiring surgery at the 5-day visit, seroma, wound infection, and chronic pain within 24 months postoperatively. Quality of life was investigated by the SF-36®.

NCT ID: NCT04960124 Completed - Healthy Clinical Trials

A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants

Start date: August 5, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics (PK) of a single oral dose of JNJ-42847922 in adult participants with hepatic impairment when compared to healthy participants with normal hepatic function.